Hayakawa M, Fujiki K, Hotta Y, Ito R, Ohki J, Ono J, Saito A, Nakayasu K, Kanai A, Ishidoh K, Kominami E, Yoshida K, Kim K C, Ohashi H
Department of Ophthalmology, Juntendo University School of Medicine, Tokyo, Japan.
Ophthalmic Genet. 1999 Jun;20(2):107-15. doi: 10.1076/opge.20.2.107.2285.
Choroideremia (CHM), an X-linked recessive hereditary disease, is an intractable chorioretinal dystrophy. The rate of disease progression of CHM reportedly shows considerable variability. A number of mutations involving the gene that codes for Rab escort protein-1 (REP-1) have been detected in CHM patients. We have analyzed REP-1 gene mutations of Japanese CHM patients. The present study was designed to investigate the clinical variability and the genotype to phenotype relationship in 15 Japanese CHM patients referred to the Department of Ophthalmology of Juntendo University Hospital. The clinical investigation of visual acuity, visual field, color vision and refraction revealed inter-individual variability. Mutation analyses of the REP-1 gene revealed 10 types of mutations in 13 patients from 11 families, including an insertion, small deletions, nonsense mutations and an A to CC mutation. In 13 CHM patients with detectable REP-1 gene mutations, no relationship of genotype to phenotype was detected. At present, we consider the REP-1 genotype to be an unreliable prognostic factor for counseling of CHM patients. In two patients from one family, no mutations were detected in coding regions of the REP-1 gene. These patients may have intron mutations of the REP-1 gene, not detectable by the techniques employed in this study, or other causative genes. Both were observed to have somewhat slower disease progression than the other 13 patients. More advanced analyses are necessary to answer questions regarding the genotype-phenotype relationship in CHM patients.
脉络膜视网膜病变(CHM)是一种X连锁隐性遗传性疾病,是一种难治性脉络膜视网膜营养不良。据报道,CHM的疾病进展速度存在很大差异。在CHM患者中已检测到许多涉及编码Rab护送蛋白-1(REP-1)的基因突变。我们分析了日本CHM患者的REP-1基因突变。本研究旨在调查转诊至顺天堂大学医院眼科的15例日本CHM患者的临床变异性以及基因型与表型的关系。对视敏度、视野、色觉和屈光的临床调查显示个体间存在变异性。REP-1基因的突变分析在来自11个家庭的13例患者中发现了10种突变类型,包括插入、小缺失、无义突变和A到CC突变。在13例可检测到REP-1基因突变的CHM患者中,未检测到基因型与表型之间的关系。目前,我们认为REP-1基因型对于CHM患者的咨询而言是一个不可靠的预后因素。在一个家庭的两名患者中,在REP-1基因的编码区域未检测到突变。这些患者可能具有本研究中所采用技术无法检测到的REP-1基因内含子突变,或者其他致病基因。观察发现这两名患者的疾病进展均比其他13例患者稍慢。需要进行更深入的分析来回答有关CHM患者基因型与表型关系的问题。